☆ 4.7 Letter

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

KIDNEY INTERNATIONAL (2022)

Get Full Text
Add to Collection

Journal

KIDNEY INTERNATIONAL
Volume 101, Issue 5, Pages 1073-1076

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2022.02.011

Keywords

Delta variant; fourth dose; kidney transplantation; mRNA vaccine; neutralizing antibodies; SARS-CoV-2

Categories

Urology & Nephrology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.